These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 127862)

  • 21. Cell-mediated immune mechanisms of tumor cell destruction.
    Perlmann P; O'Toole C; Unsgaard B
    Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune complexes in human malignant tumours. A review.
    Segal-Eiras A; Croce MV
    Allergol Immunopathol (Madr); 1984; 12(3):225-32. PubMed ID: 6382986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of tumor-induced immunological deficiencies and their possible significance in relation to the use of immunopotentiators in tumor-bearing hosts.
    Kerbel RS
    Biomedicine; 1974 Jul; 21(7):253-61. PubMed ID: 4547979
    [No Abstract]   [Full Text] [Related]  

  • 24. [Immunological interrelationships of the body and the tumor].
    Govallo VI
    Vopr Onkol; 1975; 21(10):93-102. PubMed ID: 52944
    [No Abstract]   [Full Text] [Related]  

  • 25. The nature of immune complexes in human cancer sera.
    Theofilopoulos AN; Andrews BS; Urist MM; Morton DL; Dixon FJ
    J Immunol; 1977 Aug; 119(2):657-63. PubMed ID: 886189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to carcinoembryonic antigen produced by somatic cell fusion.
    Kupchik HZ; Zurawski VR; Hurrell JG; Zamcheck N; Black PH
    Cancer Res; 1981 Sep; 41(9 Pt 1):3306-10. PubMed ID: 7260897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial and detrimental effects of humoral immunity in malignancy.
    Lewis MG; Philips TM; Rowden G
    Pathobiol Annu; 1978; 8():217-39. PubMed ID: 364374
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunodepressive action of the tumor].
    Belokhvostov AS
    Vopr Onkol; 1978; 24(3):99-106. PubMed ID: 347712
    [No Abstract]   [Full Text] [Related]  

  • 29. Free CEA binding substance in cancer sera.
    Bartorelli A
    Biomed Pharmacother; 1987; 41(1):2-5. PubMed ID: 3607252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunology of cancer: avenues to immunotherapy.
    Woods AH
    Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414
    [No Abstract]   [Full Text] [Related]  

  • 31. [Early diagnosis of cancer using monoclonal antibodies].
    Ohkura H
    Nihon Rinsho; 1985 Jul; 43(7):1525-34. PubMed ID: 2414489
    [No Abstract]   [Full Text] [Related]  

  • 32. Humoral factors influencing cell-mediated immune responses to tumour-associated antigens.
    Baldwin RW; Embleton MJ; Robins RA
    Proc R Soc Med; 1973 May; 66(5):466-8. PubMed ID: 4351926
    [No Abstract]   [Full Text] [Related]  

  • 33. Radioimmune assay for the diagnosis of human cancer.
    Egan ML; Coligan JE; Todd CW
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1504-9. PubMed ID: 4472990
    [No Abstract]   [Full Text] [Related]  

  • 34. The immunotherapy of cancer.
    Parker CW
    Pharmacol Rev; 1973 Jun; 25(2):325-42. PubMed ID: 4581047
    [No Abstract]   [Full Text] [Related]  

  • 35. Tumor-bound immunoglobulins: their possible role in circumventing antitumor immunity.
    Witz IP; Levy HJ; Keisari Y; Izsak FC
    Johns Hopkins Med J Suppl; 1974; 3():289-300. PubMed ID: 4214276
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour immunology.
    Mitchison NA
    Essays Fundam Immunol; 1973; 0(1):57-66. PubMed ID: 4547342
    [No Abstract]   [Full Text] [Related]  

  • 37. Metastatic spread and "escape" from the immune defenses of the host.
    Alexander P
    Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fifth Annual Sapporo Cancer Seminar. Monoclonal antibodies--progress in cancer immunobiology and clinical application.
    Reisfeld RA; Greene ML; Yachi A
    Cancer Res; 1986 Apr; 46(4 Pt 2):2193-6. PubMed ID: 2868789
    [No Abstract]   [Full Text] [Related]  

  • 39. [Significance of tumor markers in clinical oncology].
    Gericke D; Drahovsky D
    Med Klin; 1979 May; 74(19):701-9. PubMed ID: 88005
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement phenomenon.
    Petrányi GG
    Haematologia (Budap); 1972; 6(3):349-56. PubMed ID: 4677588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.